DR. AMELIA R FARNHAM PHARMD
NPI 1730978685
Pharmacist - Pharmacotherapy in Clinton, CT

Active since May 06, 2025
24 TOWER HILL RD, CLINTON, CT 06413(508) 207-0176 Get Directions Write a Review

NPPES record last updated: May 6, 2025. Verified against the NPPES registry weekly; last sync: July 19, 2026.

About Dr. Amelia R Farnham Pharmd NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

DR. AMELIA R FARNHAM PHARMD (NPI 1730978685) is an individual pharmacotherapy provider in Clinton, Connecticut, licensed in Massachusetts (PH238573) and active in the NPI registry since May 2025.

NPPES Registry Identity

NPI1730978685
Entity TypeIndividualFemale
Primary Taxonomy1835P1200X
Provider Legal NameDR. AMELIA R FARNHAMCredential: PHARMD
Location Address24 TOWER HILL RDClinton, CT 06413-1201
Mailing Address24 Tower Hill RdClinton, CT 06413-1201 · (508) 207-0176
Sole ProprietorYes
Enumeration DateMay 6, 2025
NPPES CertifiedMay 6, 2025
NPI 1730978685 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyPharmacist · PharmacotherapyPharmacy Service Providers
Taxonomy Code1835P1200X
Licenses Licensed in MA · PH238573 Licensed in ME · PR68727 Licensed in TX · 72395 Licensed in CA · 90587 Licensed in FL · PS68536 Licensed in SC · 60552 Licensed in VA · 0202222645
Definition

A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.

24 TOWER HILL RD, Clinton, CT 06413

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1730978685, enumerated as an "individual" on May 06, 2025.

The provider is located at 24 TOWER HILL RD CLINTON, CT 06413 and the phone number is (508) 207-0176.

Pharmacist with taxonomy code 1835P1200X and a focus in Pharmacotherapy.